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Ginseng (Order: Apiales, Family: Araliaceae, Genus: Panax) has been used as a
traditional herbal medicine for over 2000 years, and is recorded to have antianxiety,
antidepressant and cognition enhancing properties. The protective effects of ginseng on
neurological disorders are discussed in this review. Ginseng species and ginsenosides,
and their intestinal metabolism and bioavailability are briefly introduced. This is followed
by molecular mechanisms of effects of ginseng on the brain, including glutamatergic
transmission, monoamine transmission, estrogen signaling, nitric oxide (NO) production,
the Keap1/Nrf2 adaptive cellular stress pathway, neuronal survival, apoptosis, neural
stem cells and neuroregeneration, microglia, astrocytes, oligodendrocytes and cerebral
microvessels. The molecular mechanisms of the neuroprotective effects of ginseng in
Alzheimer’s disease (AD) including β-amyloid (Aβ) formation, tau hyperphosphorylation
and oxidative stress, major depression, stroke, Parkinson’s disease and multiple
sclerosis are presented. It is hoped that this discussion will stimulate more studies on
the use of ginseng in neurological disorders.
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Introduction
Ginseng (Order: Apiales, Family: Araliaceae, Genus: Panax) roots, stems, and leaves have been
used as traditional herbal medicine for over 2000 years. In Korea, China and Japan, ginseng is
the most valuable of all medicinal herbs. Its anti-anxiety, antidepressant and cognition-enhancing
effects has been recorded by Shi-Zhen Li in Ben Cao Gang Mu ( ) which is the most
comprehensive pre-modern herbal text, compiled during the Ming Dynasty in China. Panax
ginseng ( ) is mostly cultivated in Korea, the Manchuria region of China (‘‘dong bei’’) and
the coastal region of Siberia due to its sensitivity to temperature and soil conditions. Panax
quinquefolium L (American ginseng, ) is cultivated in southern Canada and the USA,
and Panax notoginseng ( ) is grown in the Yunnan and Guangxi provinces of China. These
three herbs represent the most extensively investigated species of Panax. The latter means ‘‘cure
all’’, and constituents of ginseng root produce adaptogenic, restorative, immunomodulatory,
vasodilatory, anti-inflammatory, antioxidant, anti-aging, anticancer, anti-fatigue, anti-stress
and anti-depressive effects in rodents and humans (Attele et al., 1999; Shin et al., 2000; Chang
et al., 2003; Choo et al., 2003; Cheng et al., 2005; Wang et al., 2009). The bioactive ingredients
in ginseng root include more than 60 ginsenosides, e.g., Rb1, Rb2, Rb3, Rc, Rd, Re, Rg1,
Rg2, and Rg3, as well as polysaccharides, fatty acids, oligopeptides and polyacetylenic alcohols
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(Qi et al., 2010). The purpose of this review is to discuss the
effects of ginseng on the normal brain, and its protective effects in
neurological disorders such as Alzheimer’s disease (AD), major
depression, stroke, Parkinson’s disease and multiple sclerosis. It
is hoped that will stimulate more studies on the use of ginseng in
neurological disorders.
Intestinal Metabolism and Actions of
Ginseng
Ginsenosides are triterpene saponins that have a common four
ring hydrophobic steroid-like structure with sugar moieties
(monomeric, dimeric, or trimeric) attached mainly at carbons
3, 6 and 20 (Zhu et al., 2004; Nah et al., 2007). Ginsenosides
are divided into two different structural classes: the 20 (S)-
protopanaxadiol (PD) group of ginsenosides Ra1, Ra2, Ra3, Rb1,
Rb2, Rb3, Rc, Rd, Rg3 and Rh2 and the 20 (S)-protopanaxatriol
(PT) group ginsenosides Re, Rf, Rg1, Rg2, and Rh1 (Baek
et al., 2012). Figure 1 shows the chemical structures of the two
ginsenosides Rb1 and Rg1. In addition, several new ginsenosides
such as 25-OH-pPD and 25-OH-pPT have been isolated and
characterized from the fruit. 25-OH-pPD shows strong cancer
preventing activity in vitro (Wang et al., 2007). Four malonyl
derivatives of ginsenosides Rb1, Rb2, Rc and Rd have also
been described (Fuzzati, 2004). The different sugar moieties
in ginsenosides have been proposed to provide specificity for
the therapeutic effects of ginsenosides (Zhu et al., 2004; Nah
et al., 2007). The most commonly studied ginsenosides are
Rb1, Rg1, Rg3, Re, and Rd. Intact ginsenosides are absorbed
FIGURE 1 | Chemical structure of ginsenosides Rb1 and Rg1.
Ginsenoside Rb1 is an example for 20 (S)-PD and ginsenoside Rg1 is an
example for 20 (S)-PT type of ginsenosides.
only from the intestines (the absorption rate is as low as 1 to
3.7%) and most ginsenosides are metabolized in the stomach
(acid hydrolysis) and in the intestine (bacterial hydrolysis) or
transformed to other ginsenosides. In vitro studies have indicated
that ginsenoside Rb1 is metabolized by human intestinal bacteria.
The metabolism is initiated by ginsenoside Rd (Rd) pathway
at the C-20 glucose (Rb1 → Rd → ginsenoside F2 (F2) →
Compound K (Cpd K) (Hasegawa et al., 1997; Hasegawa and
Uchiyama, 1998; Tawab et al., 2003; Hasegawa, 2004; Bae et al.,
2006; Qian et al., 2006; Chen et al., 2008b; Hou et al., 2012;
Jung et al., 2012; Zhao et al., 2012). Collective evidence suggests
that the metabolism and transformation of intact ginsenosides
is an important process, playing an important role not only in
bioavailability but also in the potential health benefits of ginseng
(Chen et al., 2008a), such as anti-tumor (Xu et al., 2007; Lee
et al., 2009), antioxidant, anti-inflammatory (Keum et al., 2003;
Bae et al., 2006), anti-fatigue and angio-suppressive effects (Yue
et al., 2006). Thus, ginseng is a natural remedy which not only
enhances phagocytosis, natural killer cell activity, psychological
function, cardiac function, and exercise performance, but also
improves immune function by enhancing the production of
interferons and increasing resistance to stress (Kiefer and
Pantuso, 2003).
Many of the beneficial effects of ginseng are mediated
through modulation of enzymes involved in signal transduction
processes (Table 1). Administration of ginseng extract over
10 days inhibited peroxisome proliferator-activated receptor-α
function, and decreased the expression of several genes involved
in lipid and lipoprotein metabolism, but increased serum
concentrations of total cholesterol, high-density lipoprotein
cholesterol and triglycerides (Yoon et al., 2003). Jiannaoning, a
Chinese herbal formula that includes ginseng leaves, improved
memory function in rats subjected to cerebral ischemia (Song
et al., 2006). It is proposed that Jiannaoning acts by regulating
the levels of proinflammatory cytokines—interleukin-2 (IL-2),
IL-6 and neuropeptide Y in the rat brain. Moreover, ginsenosides
inhibited the tumor necrosis factor-alpha (TNF-α) induced
phosphorylation of IkappaB-α (IκB-α) kinase (IKK) and the
subsequent phosphorylation and degradation of IκB-α. TNF-
α-induced phosphorylation of mitogen-activated protein kinase
kinase 4 (MKK4) and subsequent activation of the c-Jun N-
terminal kinases activator-protein 1 (JNK-AP-1) pathway was
also suppressed (Choi et al., 2007). Ginsenosides from ginseng
leaves and stems upregulated the level of glucocorticoid receptor
(GR) in the brain cytosol of heat-injured rats (Li et al., 2006).
Interactions of ginsenoids or glucocorticoids with GR triggered
cellular responses involving activation of phosphatidylinositol-
3 kinase (PI3K)/Akt pathway and increased nitric oxide (NO)
production in human umbilical vein endothelial cells (Lee
et al., 1997; Dancey, 2004). Ginsenosides may also regulate ion
channels via their ligand-binding sites or channel pore sites (Nah
et al., 2007). They inhibited voltage-dependent Ca2+, K+, and
Na+ channel activities in a stereospecific manner (Liu et al.,
2010) and blocked some subtypes of nicotinic acetylcholine
(ACh) and 5-hydroxytryptamine type 3 receptors (Chen
et al., 2010). Ginsenosides facilitated neurotransmission in the
brain (Xue et al., 2006; Liu et al., 2010) but inhibited glutamate
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TABLE 1 | Effect of ginsenosides on enzyme activities.
Enzyme Effect Reference
Superoxide dismutase Stimulation Fu and Ji (2003) and Sohn et al. (2013)
Glutathione peroxidase Stimulation Fu and Ji (2003) and Sohn et al. (2013)
Na+, K+-ATPase Inhibition Chen et al. (2009)
Phosphoinositol-3-kinase (Ptd Ins 3K)/Akt-dependent extracellular signal-regulated kinase 1/2 Stimulation Kim et al. (2007)
Endothelial nitric oxide synthase Stimulation Kim et al. (2007)
excitotoxicity (Kim et al., 2002). In addition, ginsenosides have
been reported to improve central cholinergic function, and
are used to treat memory deficits in humans (Rudakewich
et al., 2001). Ginsenosides increased levels of dopamine and
norepinephrine in the cerebral cortex (Itoh et al., 1989)
and have beneficial effects on attention, cognitive processing,
sensorimotor function and auditory reaction time in healthy
subjects (D’Angelo et al., 1986).
Bioavailability of Ginseng
The oral bioavailability of ginsenosides is very low. The
poor bioavailability of ginsenosides is not only because of
low membrane permeability and active biliary excretion,
but also due to biotransformation (Liu et al., 2009). As
mentioned above, deglycosylated products of ginsenosides are
formed by their bacterial metabolism in the gut lumen.
These products are more permeable and bioactive than
glycosylated ginsenosides (Hasegawa and Uchiyama, 1998).
Intestinal bacterial metabolites of ginseng are absorbed into the
bloodstream. Quantitative and statistical analysis of ginsenosides
in plasma indicates that protopanaxadiol (PD) saponins exhibit
higher concentration and longer half-life than protopanaxatriol
(PT) saponins (Zhang et al., 2014). The mean values of
half-lives of the ginsenosides Rg1, Re, Rb1, Rb2/b3, Rc
and Rd are 15.26, 2.46, 18.41, 27.70, 21.86 and 61.58 h;
while their peak concentrations are 7.15, 2.83, 55.32, 30.22,
21.42, 8.81 µg/L respectively (Zhang et al., 2014). Studies
on concentrations of ginsenosides in the brain at different
time intervals after dosing show that ginsenosides enter into
the brain rapidly, but concentrations decline rapidly with
time. Ginsenosides with higher concentrations in the brain
are Rg1, Re, Rb1 and Rc (Zhang et al., 2014). Rg1 and Re
may be the main components directly affecting CNS neurons,
due to their better brain distribution. On the other hand,
ginsenosides of PD saponins may protect the brain mostly
through a peripheral effect, due to their longer time in the
circulation.
Molecular Mechanisms of Effects of
Ginseng on the Brain
Effect on Glutamatergic Neurotransmission
Ginsenosides have a general stimulatory effect on the brain
(Radad et al., 2011). Ginsenoside Rb1 increased glutamate
release in neurons via the PKA-dependent signaling pathway,
whereas ginsenoside Rg1 induced glutamate release in a
calcium/calmodulin-dependent protein kinase II (CaMKII)
dependent manner (Liu et al., 2010). Ocotillol is a derivative
of pseudoginsenoside-F11, a ginsenoside found in American
ginseng, and displayed excitatory effect on spontaneous
action potential firing and depolarized the membrane
potential of mitral cells. This effect was abolished by
the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA)/kainate receptor antagonist 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) and the N-methyl-D-
aspartate receptor (NMDAR) receptor antagonist D-AP5,
suggesting a role for glutamatergic transmission in the effects
of ocotillol (Wang et al., 2011b). Transmission of action
potentials transmission in the somatosensory cortex was
facilitated by ginsenoside Rb3 perfusion (Cui et al., 2012).
Ginsenoside Rg1 supplementation improved the performance of
aged mice in behavioral tests and significantly upregulated
the expression of synaptic plasticity-associated proteins
in the hippocampus, including synaptophysin, NMDAR
subunit 1, postsynaptic density protein 95 (PSD95) and
CaMKII alpha via the mammalian target of rapamycin
(mTOR) pathway (Yang et al., 2014). Notoginsenoside
R1, a major saponin isolated from Panax notoginseng,
increased membrane excitability of CA1 pyramidal neurons
in hippocampal slices by lowering the spike threshold, possibly
through inhibition of voltage-gated K+ currents. It also
reversed Aβ1–42 oligomer-induced impairments in long-
term potentiation (Yan et al., 2014). Other studies showed
that ginsenoside Rb1 inhibited the activity of L-type voltage
gated calcium channels, without affecting N-type or P/Q-type
Ca2+ channels in hippocampal neurons (Lin et al., 2012a).
Gintonin is a newly identified compound from ginseng that
is found to activate G protein-coupled lysophosphatidic acid
(LPA1) receptors with high affinity (Hwang et al., 2012a;
Nah, 2012). Gintonin stimulated neurotransmitter release
(Hwang et al., 2015) and promoted synaptic enhancement
via LPA1 receptor activation in central synapses (Park et al.,
2015). Gintonin contains two components: ‘‘ginseng major
latex-like protein 151’’ (GLP) and ginseng ribonuclease-
like storage protein; and recent studies have determined
the structure of ginseng major latex-like protein 151 and
its proposed lysophosphatidic acid binding mechanism
(Choi et al., 2015). The LPA1 receptor is localized in
dendritic spines of cultured hippocampal neurons (Pilpel
and Segal, 2006) that are sites of glutamatergic synapses,
and further study is necessary to elucidate a possible role of
gintonin and LPA receptor signaling, in the CNS effects of
ginseng.
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Effect on Monoamine Neurotransmission
Ginsenosides could have effects on monoamine signaling.
Total saponins extracted from Panax notoginseng increased the
levels of 5-hydroxytryptamine, dopamine and noradrenaline,
suggesting that it may have antidepressant effects by modulation
of brain monoamine levels (Xiang et al., 2011).
Effect on Estrogen Signaling
Improved object recognition and decreased immobility time in
the forced swim test have been reported following ginsenoside
Rb1 treatment. Pre-treatment with an estrogen receptor
antagonist clomiphene blocked these effects, indicating that they
are dependent on the estrogen receptor (Hao et al., 2011). Red
ginseng also prevented downregulation of the ERβ estrogen
receptor in immobilization-stressed mice (Kim et al., 2013b).
Effect on Nitric Oxide Production
Ginsenosides have been shown in many studies to inhibit
inducible nitric oxide synthase (iNOS). Rg3 at 20 and 30mg/kg
oral doses modulated an increase in TNF-α, IL-1β and IL-6
mRNA after lipopolysaccharide (LPS) injection in mice (Park
et al., 2012b). Protective effects of Re treatment occurred
via the phospho-p38, iNOS, and cyclooxygenase-2 (COX-2)
signaling pathways in LPS stimulated BV-2 microglial cells (Lee
et al., 2012). A bacterial metabolite of Rg5 which is the main
constituent of heat-processed ginseng, Rh3, also decreased the
expression of iNOS and TNF-α and IL-6, and increased the
expression of heme oxygenase −1(HO-1) in LPS stimulated BV-
2 microglial cells (Lee et al., 2015). As with iNOS, neuronal nitric
oxide synthase (nNOS) is inhibited by ginseng. Ginseng saponins
are transformed by intestinal microflora, and a product Rh2
decreased the expression of nNOS in the hippocampus, while
another product Rg3 decreased its expression in the neocortex
(Jang et al., 2004). Ginsenoside Rg1 has neuroprotective effects
on ischemia-reperfusion injury in cultured hippocampal cells
by blocking calcium influx into neuronal cells and decreasing
nNOS activity (He et al., 2014). In contrast to iNOS, and nNOS,
ginsenosides appear to stimulate endothelial nitric oxide synthase
(eNOS) and may have beneficial effects on the circulation.
Ginsenoside-Rg1 increased the phosphorylation of GR, PI3K,
Akt/PKB and eNOS, leading to NO production in human
umbilical vein endothelial cells. Knockdown of GR modulated
the Rg1 induced NO production. Results indicate that Rg1 can
act as an agonist ligand for GR, and that activated GR can induce
rapid NO production from eNOS via the PI3K/Akt pathway
(Leung et al., 2006).
Effect on the Keap1/Nrf2 Adaptive Cellular Stress
Pathway (Figure 2)
This is an important adaptive pathway in response to oxidative
stress, and many studies have pointed to this pathway as
a target of dietary phytochemicals (Reviewed in Lee et al.,
2014). Under physiological conditions, Keap1 keeps the Nrf2
transcription factor in the cytoplasm, allowing it to be
ubiquitinated and degraded by proteasomes; but when cells are
exposed to neurodegenerative disease-mediated oxidative stress,
a signal involving phosphorylation and/or redox modification
in Keap1 blocks the enzymatic activity of the Keap1-Cul3-
Rbx1 E3 ubiquitin ligase complex, leading to decrease in
Nrf2 ubiquitination and degradation. As a result, free Nrf2
translocates into the nucleus, where it transactivates the
antioxidant response element (ARE) of many cytoprotective
genes (Figure 2). Rg1 pretreatment induced Nrf2 nuclear
translocation and activation of the PI3K/Akt pathway, which
could antagonize iron-induced increase in reactive oxygen
species (ROS) and decrease in mitochondrial transmembrane
potential in cultured neurons (Du et al., 2013). Likewise,
ginsenoside Rh3 increased Nrf2 DNA-binding activity and level
of sirtuin 1 (SIRT1) resulting in inhibition of NF-κB in cultured
cells (Lee et al., 2015). Protopanaxtriol extracted from Panax
ginseng increased Nrf2 entering the nucleus, and induced the
expression of phase II antioxidant enzymes, including HO-1
and nicotinamide adenine dinucleotide phosphate (NADPH)
quinone oxidase 1, after 3-nitropropionic acid induced injury
(Gao et al., 2015). Notoginsenoside R1 isolated from Panax
notoginseng increased nuclear translocation of Nrf2 and ARE
activity, and upregulated the expression and activity of HO-
1, NADPH quinone oxidase 1 and gamma-glutamylcysteine
synthetase (γ-GCSc) in PC12 cells (Meng et al., 2014). Together,
results indicate an important role of the Keap1/Nrf2 pathway in
neuroprotective effects of ginseng.
Effect on Neuronal Cell Survival
Oral administration of ginsenoside Rb1 significantly increased
cell survival but not proliferation in the hippocampus, that may
be related to its effects on learning and memory (Liu et al., 2011).
Effect on Apoptosis
Ginsenoside Rg induced downregulation of calpain I and
caspase-3 and attenuated neuronal apoptosis caused by cerebral
ischemia-reperfusion injury (He et al., 2012). Ginsenoside Rb1
is reported to suppress the activation of endoplasmic reticulum
stress-associated proteins including protein kinase RNA (PKR)-
like ER kinase (PERK) and C/EBP homology protein (CHOP)
and downregulation of Bcl-2 induced by high glucose (Liu et al.,
2013). Panax notoginseng saccharides increased Bcl-2/Bax ratio
and had anti-apoptotic and neuroprotective effects after cerebral
ischemia in rats (Jia et al., 2014).
Effect on Neural Stem Cells and
Neuroregeneration
Ginsenoside Rb1 enhanced neurotrophin expression and
induced differentiation of midbrain dopaminergic neurons
(Hsieh and Chiang, 2014). In addition, Rg1 promoted
neural stem cell differentiation through the cyclic adenosine
monophosphate-protein kinase A (cAMP-PKA) and PI3K-
AKT signaling pathways (Jiang et al., 2012a; Li et al., 2013).
Ginsenoside Rd also increased neural stem cell proliferation (Lin
et al., 2012b) and maintained neurogenesis after lead-induced
neural injury (Wang et al., 2013b). Panax notoginseng saponins
decreased the expression of the neurite inhibitory molecules
Nogo-A and NgR after cerebral ischemia in rats, suggesting a
role in axonal regeneration after injury (Liu et al., 2014).
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FIGURE 2 | Hypothetical diagram showing the effects of ginseng on
signal transduction processes in the brain. phosphatidylcholine
(PtdCho); lyso-phosphatidylcholine (lyso-PtdCho); cytosolic phospholipase
A2 (cPLA2); arachidonic acid (AA); platelet activating factor (PAF); reactive
oxygen species (ROS); Nuclear factor-kappa B (NF-κB); nuclear factor
erythroid 2-related factor 2 (Nrf2); cyclooxygenase-2 (COX-2);
lipoxygenase (LOX); secretory phospholipase A2 (sPLA2); inducible nitric
oxide synthase (iNOS); tumor necrosis factor-α (TNF-α); interleukin-1β
(IL-1β); interleukin-6 (IL-6); kelch-like erythroid Cap “n” Collar
homologue-associated protein 1 (Keap1); NFE2-related factor 2 (Nrf2);
antioxidant response element (ARE); quinine oxidoreductase (QR);
hemeoxygenase 1 (HO-1); superoxide dismutase (SOD); glutathione
peroxidase (GP); γ-glutamylcysteine ligase (γ-GCL); heat shock proteins
(HSPs); amyloid precursor protein (APP); soluble amyloid precursor protein
(sAPP); β-amyloid (Aβ); α secretase (ADAM10); and β-secretase (BACE1).
This diagram is based on information provided in Choi et al. (2010), Jung
et al. (2010), Li et al. (2010), Ye et al. (2011b), Hwang et al. (2012b),
Karpagam et al. (2013) and Wang et al. (2013c).
Effect on Microglia
Microglia are resident innate immune cells in the CNS,
which are activated in response to a variety of stimuli, such
as infection, traumatic brain injury, toxic metabolites, or
autoimmunity. Ginsenoside Rh1 inhibited the expression
of iNOS, COX-2, and pro-inflammatory cytokines while
increasing the expression of anti-inflammatory IL-10 in
LPS-stimulated microglia. These effects were attenuated
by inhibition of HO-1 (Jung et al., 2010). In addition,
ginsenoside Rb1 reversed the changes in several direct or
indirect neuroinflammatory markers in the hippocampus
(Wang et al., 2011a). Ginsenoside Rb1 also decreased the
expression of TNF-α, down regulated IL-6 expression, inhibited
the activation of NF-κB and modulated microglial activation
after brain ischemia (Zhu et al., 2012). Ginsenoside Rg1
pre-treatment of LPS induced BV-2 microglial cells activated
the phospholipase C signaling pathway and modulated the
expression of iNOS, COX-2, TNF-α, IL-1β and NF-κB (Zong
et al., 2012). A ginseng saponin metabolite, compound K
(20-O-D-glucopyranosyl-20 (S)-PD), reduced the number of
Iba1-positive activated microglia, and inhibited the expression
of TNF-α and IL-1β in the brain after LPS-induced sepsis
(Park et al., 2012a). Together, results indicate that ginseng
has anti-neuroinflammatory effects by reducing activation of
microglia.
Effect on Astrocytes
Ginsenoside Rd increased levels of phosphorylated protein
kinase B (PKB/Akt) and phospho-ERK1/2 (p-ERK1/2) and
expression of glutamate transporter-1 (GLT-1) in astrocyte
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TABLE 2 | Studies summarizing the effects of ginseng metabolites in neurological disorders.
Neurological disorder Ginseng metabolite Mechanism Reference
Stroke GinsenosideRd, GS-Rd,
Ginsenoside Rb1
Anti-inflammatory; inhibition
of Ca2+ influx, and reduction in edema
Ye et al. (2011a,b)
AD Ginsenoside CK, F1, Rh1, and Rh2;
Panax notoginseng saponins
Inhibition of Aβ aggregation, inflammation,
and antioxidant effects
Karpagam et al. (2013) and Huang et al.
(2014)
PD Ginseng extract G115 Inhibition of α-synuclein aggregation Van Kampen et al. (2014)
EAE and MS Ginsenoside Rd Regulation of IFN-γ and IL-4 Zhu et al. (2014)
Depression Ginsenosides 20 (S)
protopanaxadiol, Rg1, and Rb1
Antidepressant Upregulation of BDNF Xu et al. (2010) and Wang et al. (2013c)
cultures after oxygen-glucose deprivation. The effect of
Rd on GLT-1 expression was abolished by inhibition of
PI3K/AKT or ERK1/2 signaling pathways (Zhang et al.,
2013). Moreover, total saponins in the leaves of Panax
notoginseng reduced H2O2 induced cell death in primary
rat cortical astrocytes, likely through nuclear translocation
of Nrf2 and upregulation of antioxidant systems including
HO-1 and glutathione S-transferase (Zhou et al., 2014b).
In contrast to normal or hypoxic astrocytes, ginsenoside
Rg3 showed anti-cancer activities in malignant astrocytes
glioblastoma multiforme cells, by induction of apoptosis via
the methyl ethyl ketone (MEK) signaling pathway (Choi et al.,
2013).
Effect on Oligodendrocytes and Myelination
Administration of American ginseng Panax quinquefolium
to mice at a dose of 150 mg/kg body mass resulted
in improvement of demyelination scores after induction of
experimental autoimmune encephalomyelitis (EAE; Bowie et al.,
2012).
Effect on Cerebral Microvessels
Ginsenosides may be effective in inhibiting changes to the
cerebral microvasculature after cerebral ischemia. Weinaokang,
a preparation consisting of active compounds extracted
from Ginkgo biloba, ginseng, and Crocus sativus (saffron)
inhibited the translocation of G protein-coupled receptor
kinase 2 from the cytosol to the cell membrane, and reduced
extracellular-signal-regulated kinases (ERK1/2) phosphorylation
andmatrix metalloproteinase expression in cerebral microvessels
(Zheng et al., 2010). Ginsenoside Rg1 also modulated increase
in aquaporin 4 expression and blood brain barrier (BBB)
disruption after cerebral ischemia in rats (Zhou et al.,
2014a).
Protective Effects of Ginseng on
Neurological Disorders
Neurochemical Aspects of Neurodegenerative,
Neurotraumatic, and Neuropsychiatric Disorders
Neurodegenerative diseases include AD, Parkinson’s disease,
Huntington’s disease, and amyotrophic lateral sclerosis. They
are associated with progressive loss of cognitive function
and motor disabilities with devastating consequences to the
affected individual. Genetic factors, environmental factors
and unhealthy lifestyle have been suggested to contribute to
the pathogenesis of neurodegenerative processes (Farooqui,
2010; Seidl et al., 2014). Many neurodegenerative diseases
are accompanied by oxidative stress and neuroinflammation,
and associated with increased generation of lipid mediators,
abnormal protein aggregation, slow excitotoxicity, loss of
synapses and disintegration of neural networks, leading to
failure of neurological functions (Jellinger, 2009; Farooqui,
2010). Neurotraumatic diseases are caused by metabolic
or mechanical insult to the brain and spinal cord. They
include cerebral ischemia or stroke, spinal cord injury and
traumatic brain injury. Neurochemical events in neurotraumatic
diseases include the release of glutamate, overstimulation
of glutamate receptors, rapid calcium influx, activation
of cytosolic phospholipase A2 (cPLA2), phospholipase
C, COX-2 and NOS, induction of oxidative stress and
neuroinflammation (Farooqui, 2010). Neuropsychiatric
disorders include both neurodevelopmental disorders and
behavioral or psychological difficulties such as depression,
schizophrenia, and bipolar disorders. Impairment of cognitive
processes results in behavioral symptoms such as abnormal
thoughts or actions, delusions, and hallucinations. They
involve abnormalities in the cerebral cortex, ventral striatum
and other components of the limbic system (Gallagher,
2004).
Alzheimer’s Disease (Table 2)
Cellular Changes Induced by Ginseng
AD is the most common form of dementia, a general term
for memory loss and other intellectual abilities serious enough
to interfere with daily life. It is characterized by the presence
of extracellular plaques consisting of aggregated Aβ peptides
and neurofibrillary tangles that contains hyperphosphorylated
tau protein, as well as cerebral amyloid angiopathy, due to
Aβ deposition around the walls of arterioles or capillaries
in the brain (Reviewed in Cheng et al., 2005). Aβ peptides
are generated from amyloid precursor protein (APP) by β-
secretase (BACE1) and γ-secretase activities, and are generally
considered to be toxic to neurons, while neurofibrillary
tangles interfere with cellular transport processes. Treatment
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with Panax notoginseng flavonol glycosides inhibited the
aggregation of Aβ in a dose-dependent manner and
modulated the increase in Ca2+ and cell death triggered
by Aβ in cultured neurons. These flavonol glycosides also
reduced memory impairment in a passive avoidance task in
scopolamine-treated rats (Choi et al., 2010). Treatment of
SH-SY5Y neuroblastoma cells with gintonin, a novel LPA1
receptor activating ligand decreased Aβ1–42 release, and
attenuated Aβ1–40 induced toxicity. In addition, long-term
oral administration of gintonin attenuated amyloid plaque
deposition, and short- and long-term memory impairment
in a mouse model of AD (Hwang et al., 2012b). Fermented
ginseng also reduced Aβ1–42 levels in HeLa cells stably
expressing the Swedish mutant form of APP and decreased
memory impairment in mouse models of AD (Kim et al.,
2013a).
Effect on Aβ Formation
Ginseng may have beneficial effects in AD by reducing the
formation of Aβ oligomers (Figure 2). Chronic supplementation
with ginsenosides for 8 months in the drinking water modulated
age-related memory impairment in mice (Zhao et al., 2011).
Panax notoginseng saponins reduced brain APP mRNA levels
and improved learning and memory in senescence-accelerated
mice (Zhong et al., 2011), and daily consumption of American
ginseng helped preserve cognitive functions in senescence-
accelerated mice (Shi et al., 2012). Moreover, aged transgenic
AD mice overexpressing APP/Aβ treated with ginsenoside Rg1
showed marked decrease in cerebral Aβ levels, reversal of
neuropathological changes and protection of spatial learning
abilities and memory (Fang et al., 2012). Ginsenosides CK, F1,
Rh1 and Rh2 from Panax ginseng were found to have potential
BACE1 inhibitory activities (Karpagam et al., 2013); and Panax
notoginseng saponins increased non-amyloidogenic processing
of APP by increasing α-secretase activity, and decreased
amyloidogenic processing by decreasing BACE1 expression
(Huang et al., 2014). Ginsenoside Rh2 improved learning and
memory performance, and reduced the number of senile plaques
in brains of Tg2576 mice (Qiu et al., 2014). Results suggest
neuroprotective effects of ginsenosides by reducing Aβ levels via
stimulation of α-secretase activity and inhibition of β-secretase
activity.
Effect on tau Phosphorylation
Ginseng may also have a beneficial effect in AD by reducing
tau hyperphosphorylation and neurofibrillary tangle formation.
Total ginsenoside extracts from stems and leaves of Panax
ginseng enhanced the phosphatase activity of purified
calcineurin. This could be useful in AD, since inhibition of
calcineurin leads to tau hyperphosphorylation at multiple sites
in AD brains (Tu et al., 2009). Treatment with ginsenoside
Rd cultured cortical neurons or AD rats (10 mg/kg for 7
days) reduced okadaic acid-induced neurotoxicity and tau
hyperphosphorylation by enhancing the activities of protein
phosphatase 2A (PP2A; Li et al., 2011a). Ginsenoside Rb1
reversed aluminum exposure-induced decreased PP2A level
and tau phosphorylation in the cortex and hippocampus (Zhao
et al., 2013). Ginsenoside Rg1 (20 mg/kg) reversed memory
impairments induced by okadaic acid by decreasing levels of
phosphorylated tau and suppressing the formation of Aβ in the
brains of rats (Song et al., 2013). Results suggest neuroprotective
effect of ginsenosides by reducing tau hyperphosphorylation.
Effect on Reactive Oxygen and Nitrogen Species
Ginsenosides are reported to have antioxidant effects. Rg1
is a potential regulator of hypoxia-inducible factor-1α (HIF-
1α), and could act via this transcription factor to improve
cell survival, angiogenesis and neurogenesis (Tang et al.,
2011). Oral treatment with pseudoginsenoside-F11 (PF11), a
component of Panax quinquefolium increased the activity
of antioxidant enzymes superoxide dismutase (SOD) and
glutathione peroxidase (GSH-Px), and is associated with
improved learning and memory in a mouse model of AD
(Wang et al., 2013c). Ginsenoside Rg1 treatment modulated
Aβ25–35 induced mitochondrial dysfunction, inhibition of HIF-
1α expression and increase in reactive nitrogen species and
protein nitrotyrosination in human endothelial cells (Yan et al.,
2013).
Effect on Cholinergic and Neurotrophic Signaling
Loss of ACh is found in the brain in AD. Ginsenoside Rg5
found in Panax ginseng modulated cognitive dysfunction and
neuroinflammation in the brains of streptozotocin-induced
memory impaired rats. Acetylcholinesterase (AChE) activity
was reduced, while choline acetyltransferase (ChAT) activity
was increased in the cortex of Rg5 treated rats (Chu et al.,
2014). Ginsenosides Re and Rd also induced the expression of
ChAT/VAChT and increased the level of ACh in Neuro-2a cells
(Kim et al., 2014).
Clinical Studies on Use of Ginseng in AD
Patients in a high-dose Korean Red Ginseng group (9 g/day)
showed significant improvement on the Alzheimer’s Disease
Assessment Scale (ADAS), Clinical Dementia Rating (CDR)
after 12 weeks of Korean Red Ginseng therapy, when compared
with those in the control group (Heo et al., 2008). In the
long-term evaluation of the efficacy of Korean Red Ginseng
in patients after 24 weeks, the Korean version of the Mini
Mental Status Examination (K-MMSE) score remained without
significant decline at the 48th and 96th weeks, and similar results
were obtained with ADAS. Together, results point to long-term
beneficial effects of Korean Red Ginseng in patients with AD
(Heo et al., 2011).
Major Depression (Table 2)
Preclinical Studies
Major depressive disorder or major depression is a mental
disorder characterized by a pervasive and persistent low
mood that is accompanied by low self-esteem and by a
loss of interest or pleasure in normally enjoyable activities.
Ginseng total saponins at doses of 50 and 100 mg/kg for
7 days reduced the immobility time in the forced swim test,
which is a mouse model of depression. They also reversed
the reduction in the sucrose preference index, decrease in
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locomotor activity, as well as prolongation of latency of
feeding in a novel environment, in a chronic stress model
of depression in rats (Dang et al., 2009). Ginseng saponins
also had antidepressant effects in the corticosterone-induced
mouse model of depression (Chen et al., 2014). Mice that
received total saponins extracted from Panax notoginseng
at doses of 10–1000 mg/kg daily for 1, 7, and 14 days
showed decreased immobility time in the forced swim test.
In the chronic mild stress model, chronic total saponin
treatment (70 mg/kg) reversed depression-like behavior in rats.
Levels of 5-hydroxytryptamine, dopamine, and noradrenaline
were increased in the brains of treated rats, which could
be the basis of the antidepressant effects (Xiang et al.,
2011). Ginsenoside Rg1 upregulated BDNF signaling in the
hippocampus, down regulated serum corticosterone levels,
and reversed the decrease in dendritic spine density and
hippocampal neurogenesis caused by chronic stress (Jiang et al.,
2012b; Wang et al., 2013a). A post-metabolism compound
and intestinal metabolite of ingested ginsenosides, PD, showed
antidepressant effects in the tail suspension and forced swim
tests, in the olfactory bulbectomy rat model of depression
(Xu et al., 2010). Together with findings in the ‘‘Effect
on Glutamatergic Neurotransmission’’ ‘‘Effect on monoamine
Neurotransmission’’, ‘‘Effect on Estrogen Signalling’’, ‘‘Effect on
Neural Stem Cells and Neuroregeneration’’ sections, they suggest
that ginseng may have beneficial effects in major depression
via multiple actions: (a) increasing AMPA receptor signaling, in
a manner similar to AMPA receptor agonists or AMPAkines;
(b) increasing the level of monoamines; (c) reducing stress
related corticosteroid levels; and (d) increasing estrogen receptor
signaling and BDNF, which are related to decreased neuronal
death and improved neurogenesis.
Clinical Studies
A randomized, multicenter, double-blind parallel group study
of 193 post-menopausal women treated with ginseng and
191 treated with placebo reported significant difference in
depression scores in favor of ginseng compared with placebo
(Wiklund et al., 1999). Clinical studies on 35 female outpatients
aging from 18 to 65 years who were remitted from major
depression with residual symptoms and given Korean Red
Ginseng at a dose of 3 g/day reported significant decrease in
depressive symptoms on the Depression Residual Symptom Scale
(DRSS) and Montgomery-Åsberg Depression Rating over an
8-week period (Jeong et al., 2014). Another study of possible
casual relation between hormones, energy sources, and minerals
indicated that depression was related to serum lipids including
cholesterol, and that fermented red ginseng had beneficial effects
on depression by modulating this relation (Lee and Ji, 2014).
Stroke
Stroke or cerebrovascular event is associated with a sudden loss
of brain function, due to disturbance in blood supply to the
brain. Ginsenoside Rd (10–50 mg/kg) significantly decreased
infarct volume and was associated with a better neurological
outcome after transient middle cerebral artery occlusion
(MCAO) in rats (Ye et al., 2011a). Interestingly, ginsenoside
Rd demonstrated neuroprotection even when administered 4 h
after recirculation of transient MCAO or after onset of ischemic
stroke induced by permanent MCAO (Ye et al., 2011b). mRNA
and protein expression levels of non-selective cation channels
such as transient receptor potential melastatin (TRPM) and
acid sensing ion channels (ASIC) were significantly increased
24 h following MCAO, and these effects were attenuated by
treatment with 10 mg/kg ginsenoside Rd (Zhang et al., 2012).
High dose ginsenoside Rb1 treatment reduced neurological
deficits, brain edema, BBB disruption and the number of terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
positive cells after hemorrhagic stroke (Li et al., 2010). Significant
reduction in basilar artery vasospasm and lumen thickness was
also observed after Rb treatment (Li et al., 2011b). Results suggest
that neuroprotective effect of ginseng in stroke via inhibition of
ion channels or modulation of vasospasm. It is, however, noted
that ginseng may have a drug interaction with the anticoagulant
warfarin that could lead to increased risk of bleeding, and this
should be taken into consideration in patients who are on
warfarin.
Parkinson’s Disease
Parkinson disease is a neurodegenerative disorder affecting
mainly the motor system, as a result of death of dopaminergic
neurons in the substantia nigra. Ginsenosides investigated as
neuroprotective agents for Parkinson’s disease are Rb1, Rg1, Rd
and Re. These compounds exert neuroprotective effects through
inhibition of oxidative stress and neuroinflammation, decrease
in toxin-induced apoptosis and nigral iron levels, and regulation
of N-methyl-D-aspartate receptor channel activity (reviewed by
González-Burgos et al., 2014). Oral administration of the ginseng
extract, G115 modulated tyrosine hydroxylase-positive cell loss
in the substantia nigra, and reduced locomotor dysfunction in
the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and
1-methyl-4-phenylpyridinium (MPP+) models of Parkinson’s
disease (Van Kampen et al., 2003). G115 also reduced
dopaminergic cell loss, microgliosis, and accumulation of α-
synuclein aggregates after chronic exposure to the dietary
phytosterol glucoside, β-sitosterol β-d-glucoside or ‘‘BSSG
model’’ of chronic Parkinson’s disease (Van Kampen et al.,
2014). MPTP administration resulted in behavioral impairment,
dopaminergic neuronal death, and increased Cdk5 and p25
expression but decreased p35 expression in the nigrostriatal
system of mice, and these effects were modulated by Korean
Red Ginseng (Jun et al., 2015). Panaxatriol saponins, the
main constituents extracted from Panax notoginseng provided
neuroprotection against loss of dopaminergic neurons and
behavioral impairment after MPTP treatment (Luo et al., 2011).
Together, results suggest that ginseng may have neuroprotective
effects in Parkinson’s disease.
Multiple Sclerosis
Ginsenoside Rd has been studied in an animal model of multiple
sclerosis, EAE. Intraperitoneally administered ginsenoside Rd at
40 mg/kg/day reduced the permeability of the BBB, regulated
the secretion of interferon-gamma and IL-4, and decreased the
severity of EAE in mice (Zhu et al., 2014).
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Conclusions and Future Directions
Many ginsenosides have been isolated and characterized. The
molecular mechanisms associated with ginsenosides involve
scavenging free radicals, inhibition of inflammation, and
prevention of excitotoxicity. Animal and cell culture studies
have indicated that ginsenosides have different activities in
both physiological and pathologic conditions. The structure
activity relationship of ginsenosides has not been fully elucidated.
However, it is becoming increasingly evident that ginsenosides
produce neuroprotective effects by reducing free radical
production and enhancing brain function. Studies involving each
ginsenoside should include mechanisms of action, specificity,
structure and function relationship, detailed pharmacokinetics
and toxicity studies, and therapeutic studies in animal models
and humans. Further studies are necessary to examine the
effects of ginseng on metabotropic glutamate receptors and
transporters, and the Keap1/Nrf2 adaptive cellular pathway. The
neurological disorders for which there is most evidence from pre-
clinical and a small number of clinical studies to benefit from
ginseng are AD and major depression, and clinical trials are
necessary to confirm the efficacy of ginseng and ginsenosides
in the prevention and treatment of these, and possibly other
neurological conditions.
Acknowledgments
This work was supported by grants from the National University
Health System and the National Medical Research Council of
Singapore.
References
Attele, A. S., Wu, J. A., and Yuan, C. S. (1999). Ginseng pharmacology: multiple
constituents and multiple actions. Biochem. Pharmacol. 58, 1685–1693. doi: 10.
1016/S0006-2952(99)00212-9
Bae, E. A., Kim, E. J., Park, J. S., Kim, H. S., Ryu, J. H., and Kim, D. H.
(2006). Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and
protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated
BV-2 microglial cells. Planta Med. 72, 627–633. doi: 10.1055/s-2006-93
1563
Baek, S. H., Bae, O. N., and Park, J. H. (2012). Recent methodology in ginseng
analysis. J. Ginseng Res. 36, 119–134. doi: 10.5142/jgr.2012.36.2.119
Bowie, L. E., Roscoe, W. A., Lui, E. M., Smith, R., and Karlik, S. J. (2012). Effects of
an aqueous extract of North American ginseng on MOG (35-55)-induced EAE
in mice. Can. J. Physiol. Pharmacol. 90, 933–939. doi: 10.1139/y2012-092
Chang, Y. S., Seo, E. K., Gyllenhaal, C., and Block, K. I. (2003). Panax
ginseng: a role in cancer therapy? Integr. Cancer Ther. 2, 13–33. doi: 10.
1177/1534735403251167
Chen, R. J., Chung, T. Y., Li, F. Y., Lin, N. H., and Tzen, J. T. (2009). Effect of sugar
positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase
activity. Acta Pharmacol. Sin. 30, 61–69. doi: 10.1038/aps.2008.6
Chen, Z., Lu, T., Yue, X.,Wei, N., Jiang, Y., Chen,M., et al. (2010). Neuroprotective
effect of ginsenoside Rb1 on glutamate-induced neurotoxicity: with emphasis
on autophagy. Neurosci. Lett. 482, 264–268. doi: 10.1016/j.neulet.2010.
07.052
Chen, G., Yang, M., Song, Y., Lu, Z., Zhang, J., Huang, H., et al. (2008a).
Comparative analysis on microbial and rat metabolism of ginsenoside Rb1
by high-performance liquid chromatography coupled with tandem mass
spectrometry. Biomed. Chromatogr. 22, 779–785. doi: 10.1002/bmc.1001
Chen, G. T., Yang, M., Song, Y., Lu, Z. Q., Zhang, J. Q., Huang, H. L., et al. (2008b).
Microbial transformation of ginsenoside Rb (1) by Acremonium strictum.
Appl. Microbiol. Biotechnol. 77, 1345–1350. doi: 10.1007/s00253-007-1258-4
Chen, L., Dai, J., Wang, Z., Zhang, H., Huang, Y., and Zhao, Y. (2014). The
antidepressant effects of ginseng total saponins in male C57BL/6N mice by
enhancing hippocampal inhibitory phosphorylation of GSK-3β. Phytother. Res.
28, 1102–1106.
Cheng, Y., Shen, L. H., and Zhang, J. T. (2005). Anti-amnestic and anti-
aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta
Pharmacol. Sin. 26, 143–149. doi: 10.1111/j.1745-7254.2005.00034.x
Choi, S. H., Hong, M. K., Kim, H. J., Ryoo, N., Rhim, H., Nah, S. Y.,
et al. (2015). Structure of ginseng major latex-like protein 151
and its proposed lysophosphatidic acid-binding mechanism. Acta
Crystallogr. D Biol. Crystallogr. 71, 1039–1050. doi: 10.1107/s139900471
500259x
Choi, K., Kim, M., Ryu, J., and Choi, C. (2007). Ginsenosides compound K and Rh
(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB
and JNK pathways in human astroglial cells. Neurosci. Lett. 421, 37–41. doi: 10.
1016/j.neulet.2007.05.017
Choi, Y. J., Lee, H. J., Kang, D. W., Han, I. H., Choi, B. K., and Cho, W. H. (2013).
Ginsenoside Rg3 induces apoptosis in the U87MGhuman glioblastoma cell line
through the MEK signaling pathway and reactive oxygen species. Oncol. Rep.
30, 1362–1370. doi: 10.3892/or.2013.2555
Choi, R. C., Zhu, J. T., Leung, K. W., Chu, G. K., Xie, H. Q., Chen, V. P.,
et al. (2010). A flavonol glycoside, isolated from roots of Panax notoginseng,
reduces amyloid-beta-induced neurotoxicity in cultured neurons: signaling
transduction and drug development for Alzheimer’s disease. J. Alzheimers Dis.
19, 795–811. doi: 10.3233/JAD-2010-1293
Choo, M. K., Park, E. K., Han, M. J., and Kim, D. H. (2003). Antiallergic activity
of ginseng and its ginsenosides. Planta Med. 69, 518–522. doi: 10.1055/s-2003-
40653
Chu, S., Gu, J., Feng, L., Liu, J., Zhang, M., Jia, X., et al. (2014).
Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition
in STZ-induced memory impaired rats via attenuating neuroinflammatory
responses. Int. Immunopharmacol. 19, 317–326. doi: 10.1016/j.intimp.2014.
01.018
Cui, J., Jiang, L., and Xiang, H. (2012). Ginsenoside Rb3 exerts antidepressant-
like effects in several animal models. J. Psychopharmacol. 26, 697–713. doi: 10.
1177/0269881111415735
Dancey, J. E. (2004). Molecular targeting: PI3 kinase pathway. Ann. Oncol. 15,
iv233–iv239. doi: 10.1093/annonc/mdh932
Dang, H., Chen, Y., Liu, X., Wang, Q., Wang, L., Jia, W., et al. (2009).
Antidepressant effects of ginseng total saponins in the forced swimming test
and chronic mild stress models of depression. Prog. Neuropsychopharmacol.
Biol. Psychiatry 33, 1417–1424. doi: 10.1016/j.pnpbp.2009.07.020
D’Angelo, L., Grimaldi, R., Caravaggi, M., Marcoli, M., Perucca, E., Lecchini, S.,
et al. (1986). A double-blind, placebo-controlled clinical study on the effect
of a standardized ginseng extract on psychomotor performance in healthy
volunteers. J. Ethnopharmacol. 16, 15–22. doi: 10.1016/0378-8741(86)90063-2
Du, X., Xu, H., Jiang, H., and Xie, J. (2013). Akt/Nrf2 activated upregulation of
heme oxygenase-1 involves in the role of Rg1 against ferrous iron-induced
neurotoxicity in SK-N-SH cells. Neurotox. Res. 24, 71–79. doi: 10.1007/s12640-
012-9362-3
Fang, F., Chen, X., Huang, T., Lue, L. F., Luddy, J. S., and Yan, S. S. (2012).
Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse
model. Biochim. Biophys. Acta 1822, 286–292. doi: 10.1016/j.bbadis.2011.
10.004
Farooqui, A. A. (2010). Neurochemical Aspects of Neurotraumatic and
Neurodegenerative Diseases. New York: Springer.
Fu, Y., and Ji, L. L. (2003). Chronic ginseng consumption attenuates age-associated
oxidative stress in rats. J. Nutr. 133, 3603–3609.
Fuzzati, N. (2004). Analysis methods of ginsenosides. J. Chromatogr. B
Analyt. Technol. Biomed. Life Sci. 812, 119–133. doi: 10.1016/j.jchromb.2004.
07.039
Gallagher, S. (2004). Neurocognitive models of schizophrenia: a
neurophenomenological critique. Psychopathology 37, 8–19. doi: 10.
1159/000077014
Frontiers in Aging Neuroscience | www.frontiersin.org 9 July 2015 | Volume 7 | Article 129
Ong et al. Protective effects of ginseng on neurological disorders
Gao, Y., Chu, S. F., Li, J. P., Zhang, Z., Yan, J. Q., Wen, Z. L., et al. (2015).
Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress
in a rat model of Huntington’s disease. Acta Pharmacol. Sin. 36, 311–322.
doi: 10.1038/aps.2014.107
González-Burgos, E., Fernandez-Moriano, C., and Gómez-Serranillos, M. P.
(2014). Potential neuroprotective activity of Ginseng in Parkinson’s disease:
a review. J. Neuroimmune. Pharmacol. 10, 14–29. doi: 10.1007/s11481-014-
9569-6
Hao, K., Gong, P., Sun, S. Q., Hao, H. P., Wang, G. J., Dai, Y., et al. (2011).
Beneficial estrogen-like effects of ginsenoside Rb1, an active component
of Panax ginseng, on neural 5-HT disposition and behavioral tasks in
ovariectomized mice. Eur. J. Pharmacol. 659, 15–25. doi: 10.1016/j.ejphar.2011.
03.005
Hasegawa, H. (2004). Proof of the mysterious efficacy of ginseng: basic and
clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal
bacteria and esterificationwith fatty acid. J. Pharmacol. Sci. 95, 153–157. doi: 10.
1254/jphs.fmj04001x4
Hasegawa, H., Sung, J. H., and Benno, Y. (1997). Role of human intestinal
Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 63, 436–440.
doi: 10.1055/s-2006-957729
Hasegawa, H., and Uchiyama, M. (1998). Antimetastatic efficacy of orally
administered ginsenoside Rb1 in dependence on intestinal bacterial
hydrolyzing potential and significance of treatment with an active bacterial
metabolite. Planta Med. 64, 696–700. doi: 10.1055/s-2006-957560
He, B., Chen, P., Yang, J., Yun, Y., Zhang, X., Yang, R., et al. (2012).
Neuroprotective effect of 20 (R)-ginsenoside Rg (3) against transient focal
cerebral ischemia in rats. Neurosci. Lett. 526, 106–111. doi: 10.1016/j.neulet.
2012.08.022
He, Q., Sun, J., Wang, Q., Wang, W., and He, B. (2014). Neuroprotective effects of
ginsenoside Rg1 against oxygen-glucose deprivation in cultured hippocampal
neurons. J. Chin. Med. Assoc. 77, 142–149. doi: 10.1016/j.jcma.2014.01.001
Heo, J. H., Lee, S. T., Chu, K., Oh, M. J., Park, H. J., Shim, J. Y., et al. (2008). An
open-label trial of Korean red ginseng as an adjuvant treatment for cognitive
impairment in patients with Alzheimer’s disease. Eur. J. Neurol. 15, 865–868.
doi: 10.1111/j.1468-1331.2008.02157.x
Heo, J. H., Lee, S. T., Oh, M. J., Park, H. J., Shim, J. Y., Chu, K., et al. (2011).
Improvement of cognitive deficit in Alzheimer’s disease patients by long term
treatment with korean red ginseng. J. Ginseng Res. 35, 457–461. doi: 10.
5142/jgr.2011.35.4.457
Hou, J. G., Xue, J. J., Sun, M. Q., Wang, C. Y., Liu, L., Zhang, D. L., et al.
(2012). Highly selective microbial transformation of major ginsenoside Rb1 to
gypenoside LXXV by Esteya vermicola CNU120806. J. Appl. Microbiol. 113,
807–814. doi: 10.1111/j.1365-2672.2012.05400.x
Hsieh, W. T., and Chiang, B. H. (2014). A well-refined in vitro model derived
from human embryonic stem cell for screening phytochemicals with midbrain
dopaminergic differentiation-boosting potential for improving Parkinson’s
disease. J. Agric. Food Chem. 62, 6326–6336. doi: 10.1021/jf501640a
Huang, J., Wu, D., Wang, J., Li, F., Lu, L., Gao, Y., et al. (2014). Effects of
Panax notoginseng saponin on alpha, beta and gamma secretase involved in
Abeta deposition in SAMP8 mice. Neuroreport 25, 89–93. doi: 10.1097/wnr.
0000000000000048
Hwang, S. H., Lee, B. H., Choi, S. H., Kim,H. J., Jung, S.W., Kim,H. S., et al. (2015).
Gintonin, a novel ginseng-derived lysophosphatidic acid receptor ligand,
stimulates neurotransmitter release. Neurosci. Lett. 584, 356–361. doi: 10.
1016/j.neulet.2014.11.007
Hwang, S. H., Shin, T. J., Choi, S. H., Cho, H. J., Lee, B. H., Pyo,M. K., et al. (2012a).
Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic
acids-protein complexes and activates G protein-coupled lysophosphatidic acid
receptors with high affinity. Mol. Cells 33, 151–162. doi: 10.1007/s10059-012-
2216-z
Hwang, S. H., Shin, E. J., Shin, T. J., Lee, B. H., Choi, S. H., Kang, J., et al. (2012b).
Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates
Alzheimer’s disease-related neuropathies: involvement of non-amyloidogenic
processing. J. Alzheimers Dis. 31, 207–223. doi: 10.3233/JAD-2012-120439
Itoh, T., Zang, Y. F., Murai, S., and Saito, H. (1989). Effects of Panax ginseng
root on the vertical and horizontal motor activities and on brain monoamine-
related substances in mice. Planta Med. 55, 429–433. doi: 10.1055/s-2006-9
62058
Jang, S., Ryu, J. H., Kim, D. H., and Oh, S. (2004). Changes of [3H]MK-
801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the
prolonged ventricular infusion of transformed ginsenosides. Neurochem. Res.
29, 2257–2266. doi: 10.1007/s11064-004-7034-2
Jellinger, K. A. (2009). Recent advances in our understanding of
neurodegeneration. J. Neural Transm. 116, 1111–1162. doi: 10.1007/s00702-
009-0240-y
Jeong, H. G., Ko, Y. H., Oh, S. Y., Han, C., Kim, T., and Joe, S. H. (2014). Effect
of Korean Red Ginseng as an adjuvant treatment for women with residual
symptoms of major depression. Asia Pac. Psychiatry doi: 10.1111/appy.12169
[Epub ahead of print].
Jia, D., Deng, Y., Gao, J., Liu, X., Chu, J., and Shu, Y. (2014). Neuroprotective
effect of Panax notoginseng plysaccharides against focal cerebral ischemia
reperfusion injury in rats. Int. J. Biol. Macromol. 63, 177–180. doi: 10.1016/j.
ijbiomac.2013.10.034
Jiang, Y. H., Li, Y. B., Zhao, X. Q., Chen, D., Jiang, R., and Wang, S. L. (2012a).
[Effect of ginsenoside Rg1 on functional expression of human neural stem cells:
a patch clamp study]. Zhongguo Zhong Yao Za Zhi 37, 3477–3480.
Jiang, B., Xiong, Z., Yang, J., Wang, W., Wang, Y., Hu, Z. L., et al. (2012b).
Antidepressant-like effects of ginsenoside Rg1 are due to activation of
the BDNF signalling pathway and neurogenesis in the hippocampus.
Br. J. Pharmacol. 166, 1872–1887. doi: 10.1111/j.1476-5381.2012.
01902.x
Jun, Y. L., Bae, C. H., Kim, D., Koo, S., and Kim, S. (2015). Korean Red Ginseng
protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a
Parkinson’s disease mouse model. J. Ginseng Res. 39, 148–154. doi: 10.1016/j.
jgr.2014.10.003
Jung, I. H., Lee, J. H., Hyun, Y. J., and Kim, D. H. (2012). Metabolism of
ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing
beta-D-glucosidase from Bifidobacterium longum H-1. Biol. Pharm. Bull. 35,
573–581. doi: 10.1248/bpb.35.573
Jung, J. S., Shin, J. A., Park, E. M., Lee, J. E., Kang, Y. S., Min, S. W., et al. (2010).
Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-
stimulated microglia: critical role of the protein kinase A pathway and
hemeoxygenase-1 expression. J. Neurochem. 115, 1668–1680. doi: 10.1111/j.
1471-4159.2010.07075.x
Karpagam, V., Sathishkumar, N., Sathiyamoorthy, S., Rasappan, P., Shila, S., Kim,
Y. J., et al. (2013). Identification of BACE1 inhibitors from Panax ginseng
saponins-An Insilco approach. Comput. Biol. Med. 43, 1037–1044. doi: 10.
1016/j.compbiomed.2013.05.009
Keum, Y. S., Han, S. S., Chun, K. S., Park, K. K., Park, J. H., Lee, S. K., et al.
(2003). Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced
cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion.
Mutat. Res. 523–524, 75–85. doi: 10.1016/s0027-5107(02)00323-8
Kiefer, D., and Pantuso, T. (2003). Panax ginseng. Am. Fam. Physician 68,
1539–1542.
Kim, S., Ahn, K., Oh, T. H., Nah, S. Y., and Rhim, H. (2002). Inhibitory effect
of ginsenosides on NMDA receptor-mediated signals in rat hippocampal
neurons. Biochem. Biophys. Res. Commun. 296, 247–254. doi: 10.1016/s0006-
291x(02)00870-7
Kim, J., Kim, S. H., Lee, D. S., Lee, D. J., Kim, S. H., Chung, S., et al. (2013a). Effects
of fermented ginseng on memory impairment and beta-amyloid reduction in
Alzheimer’s disease experimental models. J. Ginseng Res. 37, 100–107. doi: 10.
5142/jgr.2013.37.100
Kim, E. H., Kim, I. H., Lee, M. J., Thach Nguyen, C., Ha, J. A., Lee, S. C., et al.
(2013b). Anti-oxidative stress effect of red ginseng in the brain is mediated by
peptidyl arginine deiminase type IV (PADI4) repression via estrogen receptor
(ER) beta up-regulation. J. Ethnopharmacol. 148, 474–485. doi: 10.1016/j.jep.
2013.04.041
Kim, Y. M., Namkoong, S., Yun, Y. G., Hong, H. D., Lee, Y. C., Ha, K. S.,
et al. (2007). Water extract of Korean red ginseng stimulates angiogenesis by
activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human
umbilical vein endothelial cells. Biol. Pharm. Bull. 30, 1674–1679. doi: 10.
1248/bpb.30.1674
Kim, M. S., Yu, J. M., Kim, H. J., Kim, H. B., Kim, S. T., Jang, S. K., et al.
(2014). Ginsenoside Re and Rd enhance the expression of cholinergic markers
and neuronal differentiation in Neuro-2a cells. Biol. Pharm. Bull. 37, 826–833.
doi: 10.1248/bpb.b14-00011
Frontiers in Aging Neuroscience | www.frontiersin.org 10 July 2015 | Volume 7 | Article 129
Ong et al. Protective effects of ginseng on neurological disorders
Lee, Y. J., Chung, E., Lee, K. Y., Lee, Y. H., Huh, B., and Lee, S. K. (1997).
Ginsenoside-Rg1, one of the major active molecules from Panax ginseng,
is a functional ligand of glucocorticoid receptor. Mol. Cell. Endocrinol. 133,
135–140. doi: 10.1016/s0303-7207(97)00160-3
Lee, K. J., and Ji, G. E. (2014). The effect of fermented red ginseng on depression
is mediated by lipids. Nutr. Neurosci. 17, 7–15. doi: 10.1179/1476830513y.
0000000059
Lee, J., Jo, D. G., Park, D., Chung, H. Y., and Mattson, M. P. (2014). Adaptive
cellular stress pathways as therapeutic targets of dietary phytochemicals: focus
on the nervous system. Pharmacol. Rev. 66, 815–868. doi: 10.1124/pr.113.
007757
Lee, K. W., Jung, S. Y., Choi, S. M., and Yang, E. J. (2012). Effects of ginsenoside
Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC
Complement. Altern. Med. 12:196. doi: 10.1186/1472-6882-12-196
Lee, S. Y., Kim, G. T., Roh, S. H., Song, J. S., Kim, H. J., Hong, S. S., et al.
(2009). Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in
human colon cancer cell lines. Biosci. Biotechnol. Biochem. 73, 811–816. doi: 10.
1271/bbb.80637
Lee, Y. Y., Park, J. S., Lee, E. J., Lee, S. Y., Kim, D. H., Kang, J. L.,
et al. (2015). Anti-inflammatory mechanism of ginseng saponin metabolite
Rh3 in lipopolysaccharide-stimulated microglia: critical role of 5’-adenosine
monophosphate-activated protein kinase signaling pathway. J. Agric. Food
Chem. 63, 3472–3480. doi: 10.1021/jf506110y
Leung, K. W., Cheng, Y. K., Mak, N. K., Chan, K. K., Fan, T. P., and Wong,
R. N. (2006). Signaling pathway of ginsenoside-Rg1 leading to nitric oxide
production in endothelial cells. FEBS Lett. 580, 3211–3216. doi: 10.1016/j.
febslet.2006.04.080
Li, M., Ling, C. Q., Huang, X. Q., and Shen, Z. L. (2006). [Effects of ginsenosides
extracted from ginseng stem and leaves on glucocorticoid receptor in different
viscera in heat-damaged rats]. Zhong Xi Yi Jie He Xue Bao 4, 156–159. doi: 10.
3736/jcim20060210
Li, L., Liu, J., Yan, X., Qin, K., Shi, M., Lin, T., et al. (2011a). Protective
effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in
vivo and in vitro. J. Ethnopharmacol. 138, 135–141. doi: 10.1016/j.jep.2011.
08.068
Li, Y., Tang, J., Khatibi, N. H., Zhu, M., Chen, D., Tu, L., et al. (2011b). Treatment
with ginsenoside rb1, a component of panax ginseng, provides neuroprotection
in rats subjected to subarachnoid hemorrhage-induced brain injury. Acta
Neurochir. Suppl. 110, 75–79. doi: 10.1007/978-3-7091-0356-2_14
Li, Y., Tang, J., Khatibi, N. H., Zhu, M., Chen, D., Zheng, W., et al. (2010).
Ginsenoside Rbeta1 reduces neurologic damage, is anti-apoptotic and down-
regulates p53 and BAX in subarachnoid hemorrhage. Curr. Neurovasc. Res. 7,
85–94. doi: 10.2174/156720210791184952
Li, Y. B., Zhao, X. Q., Jiang, Y. H., Chen, D., and Wang, S. L. (2013). [Study
on molecular target promoting human neural stem cells of ginsenoside
Rg1 by gene chip]. Zhongguo Zhong Yao Za Zhi 38, 2701–2705. doi: 10.
4268/cjcmm20131631
Lin, Z. Y., Chen, L. M., Zhang, J., Pan, X. D., Zhu, Y. G., Ye, Q. Y., et al.
(2012a). Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-
gated calcium channels in cultured rat hippocampal neurons. Acta Pharmacol.
Sin. 33, 438–444. doi: 10.1038/aps.2011.181
Lin, T., Liu, Y., Shi, M., Liu, X., Li, L., Liu, Y., et al. (2012b). Promotive effect
of ginsenoside Rd on proliferation of neural stem cells in vivo and in vitro.
J. Ethnopharmacol. 142, 754–761. doi: 10.1016/j.jep.2012.05.057
Liu, L., Hoang-Gia, T., Wu, H., Lee, M. R., Gu, L., Wang, C., et al. (2011).
Ginsenoside Rb1 improves spatial learning and memory by regulation of cell
genesis in the hippocampal subregions of rats. Brain Res. 1382, 147–154.
doi: 10.1016/j.brainres.2011.01.051
Liu, H., Yang, J., Du, F., Gao, X., Ma, X., Huang, Y., et al. (2009). Absorption
and disposition of ginsenosides after oral administration of Panax notoginseng
extract to rats. Drug Metab. Dispos. 37, 2290–2298. doi: 10.1124/dmd.109.
029819
Liu, D., Zhang, H., Gu, W., Liu, Y., and Zhang, M. (2013). Neuroprotective
effects of ginsenoside Rb1 on high glucose-induced neurotoxicity in primary
cultured rat hippocampal neurons. PLoS One 8:e79399. doi: 10.1371/journal.
pone.0079399
Liu, Z. J., Zhao, M., Zhang, Y., Xue, J. F., and Chen, N. H. (2010). Ginsenoside
Rg1 promotes glutamate release via a calcium/calmodulin-dependent protein
kinase II-dependent signaling pathway. Brain Res. 1333, 1–8. doi: 10.1016/j.
brainres.2010.03.096
Liu, L., Zhu, L., Zou, Y., Liu, W., Zhang, X., Wei, X., et al. (2014). Panax
notoginseng saponins promotes stroke recovery by influencing expression of
Nogo-A, NgR and p75NGF, in vitro and in vivo. Biol. Pharm. Bull. 37, 560–568.
doi: 10.1248/bpb.b13-00770
Luo, F. C.,Wang, S. D., Qi, L., Song, J. Y., Lv, T., and Bai, J. (2011). Protective effect
of panaxatriol saponins extracted from Panax notoginseng against MPTP-
induced neurotoxicity in vivo. J. Ethnopharmacol. 133, 448–453. doi: 10.1016/j.
jep.2010.10.017
Meng, X., Sun, G., Ye, J., Xu, H., Wang, H., and Sun, X. (2014). Notoginsenoside
R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk
between Akt and ERK1/2 pathways: a novel mechanism of Nrf2/ARE
signaling activation. Free Radic. Res. 48, 445–460. doi: 10.3109/10715762.2014.
885117
Nah, S. Y. (2012). Gintonin: a novel ginseng-derived ligand that targets G protein-
coupled lysophosphatidic acid receptors. Curr. Drug Targets 13, 1659–1664.
doi: 10.2174/138945012803529947
Nah, S. Y., Kim, D. H., and Rhim, H. (2007). Ginsenosides: are any of them
candidates for drugs acting on the central nervous system? CNS Drug Rev. 13,
381–404.
Park, H., Kim, S., Rhee, J., Kim, H. J., Han, J. S., Nah, S. Y., et al. (2015). Synaptic
enhancement induced by gintonin via lysophosphatidic acid receptor activation
in central synapses. J. Neurophysiol. 113, 1493–1500. doi: 10.1152/jn.00667.
2014
Park, J. S., Shin, J. A., Jung, J. S., Hyun, J. W., Van Le, T. K., Kim,
D. H., et al. (2012a). Anti-inflammatory mechanism of compound K in
activated microglia and its neuroprotective effect on experimental stroke
in mice. J. Pharmacol. Exp. Ther. 341, 59–67. doi: 10.1124/jpet.111.
189035
Park, S. M., Choi, M. S., Sohn, N. W., and Shin, J. W. (2012b). Ginsenoside
Rg3 attenuates microglia activation following systemic lipopolysaccharide
treatment in mice. Biol. Pharm. Bull. 35, 1546–1552. doi: 10.1248/bpb.b12-
00393
Pilpel, Y., and Segal, M. (2006). The role of LPA1 in formation of synapses among
cultured hippocampal neurons. J. Neurochem. 97, 1379–1392. doi: 10.1111/j.
1471-4159.2006.03825.x
Qi, X., Ignatova, S., Luo, G., Liang, Q., Jun, F. W., Wang, Y., et al. (2010).
Preparative isolation and purification of ginsenosides Rf, Re, Rd and Rb1 from
the roots of Panax ginseng with a salt/containing solvent system and flow step-
gradient by high performance counter-current chromatography coupled with
an evaporative light scattering detector. J. Chromatogr. A 1217, 1995–2001.
doi: 10.1016/j.chroma.2010.01.057
Qian, T., Jiang, Z. H., and Cai, Z. (2006). High-performance liquid
chromatography coupled with tandem mass spectrometry applied for
metabolic study of ginsenoside Rb1 on rat. Anal. Biochem. 352, 87–96. doi: 10.
1016/j.ab.2006.02.025
Qiu, J., Li, W., Feng, S. H., Wang, M., and He, Z. Y. (2014). Ginsenoside
Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via
a cholesterol-dependent pathway. Genet. Mol. Res. 13, 3586–3598. doi: 10.
4238/2014.may.9.2
Radad, K., Moldzio, R., and Rausch, W. D. (2011). Ginsenosides and their
CNS targets. CNS Neurosci. Ther. 17, 761–768. doi: 10.1111/j.1755-5949.2010.
00208.x
Rudakewich, M., Ba, F., and Benishin, C. G. (2001). Neurotrophic and
neuroprotective actions of ginsenosides Rb (1) and Rg (1). Planta Med. 67,
533–537. doi: 10.1055/s-2001-16488
Seidl, S. E., Santiago, J. A., Bilyk, H., and Potashkin, J. A. (2014). The emerging
role of nutrition in Parkinson’s disease. Front. Aging Neurosci. 6:36. doi: 10.
3389/fnagi.2014.00036
Shi, S., Shi, R., and Hashizume, K. (2012). American ginseng improves
neurocognitive function in senescence-accelerated mice: possible role of the
upregulated insulin and choline acetyltransferase gene expression. Geriatr.
Gerontol. Int. 12, 123–130. doi: 10.1111/j.1447-0594.2011.00719.x
Shin, H. R., Kim, J. Y., Yun, T. K., Morgan, G., and Vainio, H. (2000). The cancer-
preventive potential of Panax ginseng: a review of human and experimental
evidence. Cancer Causes Control 11, 565–576. doi: 10.1023/A:10089
80200583
Frontiers in Aging Neuroscience | www.frontiersin.org 11 July 2015 | Volume 7 | Article 129
Ong et al. Protective effects of ginseng on neurological disorders
Sohn, S. H., Kim, S. K., Kim, Y. O., Kim, H. D., Shin, Y. S., Yang, S. O., et al. (2013).
A comparison of antioxidant activity of Korean White and Red Ginsengs on
H2O2-induced oxidative stress in HepG2 hepatoma cells. J. Ginseng Res. 37,
442–450. doi: 10.5142/jgr.2013.37.442
Song, X. Y., Hu, J. F., Chu, S. F., Zhang, Z., Xu, S., Yuan, Y. H., et al.
(2013). Ginsenoside Rg1 attenuates okadaic acid induced spatial memory
impairment by the GSK3β/tau signaling pathway and the Abeta formation
prevention in rats. Eur. J. Pharmacol. 710, 29–38. doi: 10.1016/j.ejphar.2013.
03.051
Song, C. S., Shi, Y., Song, J., Tian, J. J., Guo, J. Z., Dai, J. X., et al. (2006). Effect
of qutan huoluo jiannao preparation in improving memory impairment of rats
with cerebral ischemia. Chin. J. Clin. Rehabil. 10, 32–35.
Tang, B., Qu, Y., Wang, D., and Mu, D. (2011). Targeting hypoxia inducible
factor-1alpha: a novel mechanism of ginsenoside Rg1 for brain repair after
hypoxia/ischemia brain damage. CNS Neurol. Disord. Drug Targets 10,
235–238. doi: 10.2174/187152711794480456
Tawab, M. A., Bahr, U., Karas, M., Wurglics, M., and Schubert-Zsilavecz, M.
(2003). Degradation of ginsenosides in humans after oral administration. Drug
Metab. Dispos. 31, 1065–1071. doi: 10.1124/dmd.31.8.1065
Tu, L. H., Ma, J., Liu, H. P., Wang, R. R., and Luo, J. (2009). The neuroprotective
effects of ginsenosides on calcineurin activity and tau phosphorylation in SY5Y
cells. Cel. Mol. Neurobiol. 29, 1257–1264. doi: 10.1007/s10571-009-9421-3
Van Kampen, J. M., Baranowski, D. B., Shaw, C. A., and Kay, D. G. (2014). Panax
ginseng is neuroprotective in a novel progressive model of Parkinson’s disease.
Exp. Gerontol. 50, 95–105. doi: 10.1016/j.exger.2013.11.012
Van Kampen, J., Robertson, H., Hagg, T., and Drobitch, R. (2003).
Neuroprotective actions of the ginseng extract G115 in two rodent models of
Parkinson’s disease. Exp. Neurol. 184, 521–529. doi: 10.1016/j.expneurol.2003.
08.002
Wang, Y., Feng, Y., Fu, Q., and Li, L. (2013a). Panax notoginsenoside Rb1
ameliorates Alzheimer’s disease by upregulating brain-derived neurotrophic
factor and downregulating Tau protein expression. Exp. Ther. Med. 6,826–830.
Wang, B., Feng, G., Tang, C., Wang, L., Cheng, H., Zhang, Y., et al. (2013b).
Ginsenoside Rd maintains adult neural stem cell proliferation during lead-
impaired neurogenesis. Neurol. Sci. 34, 1181–1188. doi: 10.1007/s10072-012-
1215-6
Wang, C. M., Liu, M. Y., Wang, F., Wei, M. J., Wang, S., Wu, C. F., et al.
(2013c). Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models
of Alzheimer’s disease. Pharmacol. Biochem. Behav. 106, 57–67. doi: 10.1016/j.
pbb.2013.03.010
Wang, Y., Liu, J., Zhang, Z., Bi, P., Qi, Z., and Zhang, C. (2011a). Anti-
neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer
disease. Neurosci. Lett. 487, 70–72. doi: 10.1016/j.neulet.2010.09.076
Wang, Z. J., Sun, L., Peng, W., Ma, S., Zhu, C., Fu, F., et al. (2011b). Ginseng
derivative ocotillol enhances neuronal activity through increased glutamate
release: a possible mechanism underlying increased spontaneous locomotor
activity of mice.Neuroscience 195, 1–8. doi: 10.1016/j.neuroscience.2011.08.002
Wang, H., Peng, D., and Xie, J. (2009). Ginseng leaf-stem: bioactive constituents
and pharmacological functions. Chin. Med. 4:20. doi: 10.1186/1749-8546-4-20
Wang, W., Zhao, Y., Rayburn, E. R., Hill, D. L., Wang, H., and Zhang, R. (2007).
In vitro anti-cancer activity and structure-activity relationships of natural
products isolated from fruits of Panax ginseng. Cancer Chemother. Pharmacol.
59, 589–601. doi: 10.1007/s00280-006-0300-z
Wiklund, I. K., Mattsson, L. A., Lindgren, R., and Limoni, C. (1999). Effects of
a standardized ginseng extract on quality of life and physiological parameters
in symptomatic postmenopausal women: a double-blind, placebo-controlled
trial. Swedish alternative medicine group. Int. J. Clin. Pharmacol. Res.
19, 89–99.
Xiang, H., Liu, Y., Zhang, B., Huang, J., Li, Y., Yang, B., et al. (2011).
The antidepressant effects and mechanism of action of total saponins
from the caudexes and leaves of Panax notoginseng in animal models
of depression. Phytomedicine 18, 731–738. doi: 10.1016/j.phymed.2010.
11.014
Xu, C., Teng, J., Chen, W., Ge, Q., Yang, Z., Yu, C., et al. (2010). 20
(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong
antidepressant-like effects in animal tests. Prog. Neuropsychopharmacol.
Biol. Psychiatry 34, 1402–1411. doi: 10.1016/j.pnpbp.2010.
07.010
Xu, T. M., Xin, Y., Cui, M. H., Jiang, X., and Gu, L. P. (2007). Inhibitory
effect of ginsenoside Rg3 combined with cyclophosphamide on growth and
angiogenesis of ovarian cancer. Chin. Med. J. (Engl) 120, 584–588.
Xue, J. F., Liu, Z. J., Hu, J. F., Chen, H., Zhang, J. T., and Chen,
N. H. (2006). Ginsenoside Rb1 promotes neurotransmitter release by
modulating phosphorylation of synapsins through a cAMP-dependent
protein kinase pathway. Brain Res. 1106, 91–98. doi: 10.1016/j.brainres.2006.
05.106
Yan, S., Li, Z., Li, H., Arancio, O., and Zhang, W. (2014). Notoginsenoside
R1 increases neuronal excitability and ameliorates synaptic and memory
dysfunction following amyloid elevation. Sci. Rep. 4:6352. doi: 10.
1038/srep06352
Yan, J., Liu, Q., Dou, Y., Hsieh, Y., Liu, Y., Tao, R., et al. (2013). Activating
glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside
Rg1 protection against beta-amyloid peptide-induced human endothelial
cells apoptosis. J. Ethnopharmacol. 147, 456–466. doi: 10.1016/j.jep.2013.
03.039
Yang, L., Zhang, J., Zheng, K., Shen, H., and Chen, X. (2014). Long-term
ginsenoside Rg1 supplementation improves age-related cognitive decline by
promoting synaptic plasticity associated protein expression in C57BL/6J
mice. J. Gerontol. A Biol. Sci. Med. Sci. 69, 282–294. doi: 10.1093/gerona/
glt091
Ye, R., Kong, X., Yang, Q., Zhang, Y., Han, J., Li, P., et al. (2011a). Ginsenoside
rd in experimental stroke: superior neuroprotective efficacy with a wide
therapeutic window. Neurotherapeutics 8, 515–525. doi: 10.1007/s13311-011-
0051-3
Ye, R., Yang, Q., Kong, X., Han, J., Zhang, X., Zhang, Y., et al. (2011b). Ginsenoside
Rd attenuates early oxidative damage and sequential inflammatory response
after transient focal ischemia in rats. Neurochem. Int. 58, 391–398. doi: 10.
1016/j.neuint.2010.12.015
Yoon, M., Lee, H., Jeong, S., Kim, J. J., Nicol, C. J., Nam, K. W., et al. (2003).
Peroxisome proliferator-activated receptor alpha is involved in the regulation
of lipid metabolism by ginseng. Br. J. Pharmacol. 138, 1295–1302. doi: 10.
1038/sj.bjp.0705169
Yue, P. Y., Wong, D. Y., Wu, P. K., Leung, P. Y., Mak, N. K., Yeung, H. W.,
et al. (2006). The angiosuppressive effects of 20 (R)- ginsenoside Rg3. Biochem.
Pharmacol. 72, 437–445. doi: 10.1016/j.bcp.2006.04.034
Zhang, Y., Lin, L., Liu, G. Y., Liu, J. X., and Li, T. (2014). [Pharmacokinetics and
brain distribution of ginsenosides after administration of sailuotong].
Zhongguo Zhong Yao Za Zhi 39, 316–321. doi: 10.4268/cjcmm20
140230
Zhang, X., Shi, M., Bjørås, M., Wang, W., Zhang, G., Han, J., et al. (2013).
Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate
transporter GLT-1 via PI3K/AKT and ERK1/2 pathways. Front. Pharmacol.
4:152. doi: 10.3389/fphar.2013.00152
Zhang, Y., Zhou, L., Zhang, X., Bai, J., Shi, M., and Zhao, G. (2012). Ginsenoside-
Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats
after focal cerebral ischemia. Neurol. Sci. 33, 1125–1131. doi: 10.1007/s10072-
011-0916-6
Zhao, H. H., Di, J., Liu, W. S., Liu, H. L., Lai, H., and üu, Y. L. (2013). Involvement
of GSK3 and PP2A in ginsenoside Rb1’s attenuation of aluminum-induced tau
hyperphosphorylation. Behav. Brain Res. 241, 228–234. doi: 10.1016/j.bbr.2012.
11.037
Zhao, X., Gao, J., Song, C., Fang, Q., Wang, N., Zhao, T., et al. (2012). Fungal
sensitivity to and enzymatic deglycosylation of ginsenosides. Phytochemistry
78, 65–71. doi: 10.1016/j.phytochem.2012.02.027
Zhao, H. F., Li, Q., and Li, Y. (2011). Long-term ginsenoside administration
prevents memory loss in aged female C57BL/6J mice by modulating
the redox status and up-regulating the plasticity-related proteins in
hippocampus. Neuroscience 183, 189–202. doi: 10.1016/j.neuroscience.2011.
03.048
Zheng, Y. Q., Liu, J. X., Li, X. Z., and Xu, L. (2010). Effects and mechanism of
Weinaokang on reperfusion-induced vascular injury to cerebral microvessels
after global cerebral ischemia. Chin. J. Integr. Med. 16, 145–150. doi: 10.
1007/s11655-010-0145-5
Zhong, Z. G., Lv, L., Chai, L. M.,Wu, D. P., Zhang,W. Y., Huang, J. L., et al. (2011).
[Effect of Panax notoginseng saponins on APP gene transcription in the brain
tissue of SAMP8]. Zhong Yao Cai 34, 77–80.
Frontiers in Aging Neuroscience | www.frontiersin.org 12 July 2015 | Volume 7 | Article 129
Ong et al. Protective effects of ginseng on neurological disorders
Zhou, Y., Li, H. Q., Lu, L., Fu, D. L., Liu, A. J., Li, J. H., et al. (2014a). Ginsenoside
Rg1 provides neuroprotection against blood brain barrier disruption and
neurological injury in a rat model of cerebral ischemia/reperfusion through
downregulation of aquaporin 4 expression. Phytomedicine 21, 998–1003.
doi: 10.1016/j.phymed.2013.12.005
Zhou, N., Tang, Y., Keep, R. F., Ma, X., and Xiang, J. (2014b). Antioxidative effects
of Panax notoginseng saponins in brain cells. Phytomedicine 21, 1189–1195.
doi: 10.1016/j.phymed.2014.05.004
Zhu, J., Jiang, Y., Wu, L., Lu, T., Xu, G., and Liu, X. (2012). Suppression of
local inflammation contributes to the neuroprotective effect of ginsenoside
Rb1 in rats with cerebral ischemia. Neuroscience 202, 342–351. doi: 10.1016/j.
neuroscience.2011.11.070
Zhu, D., Liu, M., Yang, Y., Ma, L., Jiang, Y., Zhou, L., et al. (2014).
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis
in C57BL/6 mice. J. Neurosci. Res. 92, 1217–1226. doi: 10.1002/jnr.
23397
Zhu, S., Zou, K., Cai, S., Meselhy, M. R., and Komatsu, K. (2004). Simultaneous
determination of triterpene saponins in ginseng drugs by high-performance
liquid chromatography. Chem. Pharm. Bull (Tokyo) 52, 995–998. doi: 10.
1248/cpb.52.995
Zong, Y., Ai, Q. L., Zhong, L. M., Dai, J. N., Yang, P., He, Y., et al.
(2012). Ginsenoside Rg1 attenuates lipopolysaccharide-induced inflammatory
responses via the phospholipase C-gamma1 signaling pathway in murine BV-
2 microglial cells. Curr. Med. Chem. 19, 770–779. doi: 10.2174/09298671279
8992066
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Ong, Farooqui, Koh, Farooqui and Ling. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution and reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 13 July 2015 | Volume 7 | Article 129
